Solid-Phase Disulfide Cyclization for Scalable Setmelanotide Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing setmelanotide, such as those described in US20120226018A1 and CN111718408A, are inefficient for large-scale production due to complex steps and high solvent requirements, particularly when forming the disulfide bond in a solution phase.
Innovation Solution
A solid-phase synthesis method where the disulfide bond is formed directly on a peptide resin without a protective group, followed by cyclization and cleavage, using specific resins, oxidizing agents, and solvents to reduce solvent use and facilitate large-scale production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If solution-phase peptide synthesis is used to prepare setmelanotide, then the disulfide bond can be formed, but the process requires complicated steps and large reaction volume, making large-scale production difficult
Solution Approach 1:
The patent transitions the disulfide bond formation from solution phase to solid phase (resin-bound), representing a dimensional change in the reaction medium. This allows the cyclization to occur while the peptide is anchored to the resin, eliminating the need for concentration adjustments and reducing solvent volumes required for large-scale production.
Solution Approach 2:
The patent performs the disulfide bond formation (cyclization) before the final cleavage from the resin. This preliminary action ensures that the cyclic structure is established while the peptide is still attached to the solid support, simplifying the overall process and enabling easier scaling.
2Reliability
If solid-phase synthesis with solution-phase cyclization is used (as in CN111718408A), then the disulfide bond can be formed, but extremely low reaction concentration (3 mg/ml) is required, producing many impurities and requiring extremely high amounts of liquid, making large-scale production difficult
Solution Approach 1:
The patent performs cyclization in the solid phase (on resin) rather than in solution, fundamentally changing the reaction dimension. This eliminates the constraint of requiring extremely low concentrations (3 mg/ml) and大幅 reduces the volume of liquid reagents needed, as the reaction occurs on the solid support with minimal solvent.
Solution Approach 2:
The patent changes the reaction concentration parameter from extremely low (3 mg/ml in solution) to effectively high concentration in solid phase. The peptide is immobilized on resin at high local concentration, enabling efficient disulfide bond formation without requiring large volumes of solvent.
3Ease of manufacture
If solid-phase synthesis with subsequent solution-phase cyclization is used, then the peptide can be synthesized, but large amounts of liquid are required in the last step, reducing productivity for industrial production
Solution Approach 1:
By performing cyclization in the solid phase rather than transferring to solution phase, the patent eliminates the solvent-intensive step. The reaction occurs on the resin with minimal solvent, dramatically reducing the volume of liquid required and enabling scalable industrial production.
Solution Approach 2:
The patent merges the cyclization step with the solid-phase synthesis process, performing both linear synthesis and cyclic formation on the resin. This integration eliminates the need for separate solution-phase cyclization and associated large solvent volumes, improving productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for increased production capacity of setmelanotide by minimizing solvent use and simplifying the process, making it suitable for industrial applications.
Implementation Method 1
putting the peptide resin without cyclization of a setmelanotide protective group in a reaction solvent containing an oxidizing agent
Implementation Method 2
adding a reducing agent to remove the unreacted oxidizing agent
Implementation Method 3
adding a cleavage reagent to obtain a cyclized setmelanotide solution
Implementation Method 4
dropping the cyclized setmelanotide solution into an ether for precipitation to obtain crude setmelanotide
Data Source
AI summary
The present disclosure provides a preparation method of setmelanotide by cyclization of a disulfide bond in a solid phase. By using different solvents or mixed solvents to carry out a cyclization reaction in a solid phase, the reaction concentration can be greatly increased in comparison with a cyclization reaction in a liquid phase, and the production of impurities can also be reduced, so that the effects of reducing the use of the solvents and increasing the production capacity are achieved.